According to a new market research report “Global Vascular Imaging Systems Market Size, Share, Development, Growth and Demand Forecast to 2023 - Industry Insights by Product (CT, MRI, X-Ray, Ultrasound and Nuclear Imaging), by Application (Cardiology, Oncology, Neurology and Others), by End User (Hospitals, Specialty Clinics and Diagnostic Centers)” published by P&S Market Research, the global vascular imaging systems market is expected to grow at a CAGR of 5.7%, during 2017 - 2023.
Increasing healthcare expenditure drives the global market
According to the study, the global vascular imaging systems market is likely to grow significantly, during the forecast period, due to increasing healthcare expenditure, increasing prevalence of cancer and cardiovascular diseases and rising awareness about imaging techniques due to various conferences and seminars. In addition, growing geriatric population and launch of technologically advanced products contribute to the growth of the market. High cost, stringent regulatory requirements, shortage of helium for magnetic resonance imaging and increasing risk of cancer due to exposure to radiations are the key factors restraining the global market growth.
Browse Report Overview at: https://www.psmarketresearch.com/market-analysis/vascular-imaging-systems-market
Insights on market segments
As per the findings of research, based on product, the CT imaging system is the most preferred vascular imaging system, globally. Based on application, cardiology holds the maximum share of the global market. Hospitals have been the largest end users of the global vascular imaging systems market.
North America stands as the largest vascular imaging systems market
Geographically, North America has been the largest market for vascular imaging systems, where the U.S. has been the largest contributor to the regional market. Increasing awareness about imaging techniques has been driving the growth of the North American market. In Europe, Germany has been the largest contributor to the market, followed by the U.K. and France. Asia-Pacific market is expected to grow at the highest CAGR, during 2017 - 2023, owing to increasing prevalence of cancer and cardiovascular diseases.
Increasing prevalence of cardiovascular diseases and cancer supports the market growth
The factors driving the growth of the market include increasing prevalence of cardiovascular diseases and cancer and aging population. According to the International Agency for Research on Cancer (IARC), a specialized cancer agency of World Health Organization (WHO) that promotes cancer research, in 2008, 12.7 million new patients were detected with cancer globally, and the number is expected to reach 21.4 million by 2030. In addition, according to WHO, 8.2 million deaths took place in 2012, globally, due to cancer, out of which 1.6 million deaths were due to lung cancer, while the reason for 745,000 deaths was liver cancer and 400,000 deaths occurred due to esophageal cancer.
According to the Conference of Radiation Control Program Directors, Inc. (CRCPD), around 62 million CT procedures are performed every year in the U.S. including 4 million CT procedures performed for children. Moreover, according to the European Association of Nuclear Medicine (EANM) annual congress, the number of patients in Western Europe undergoing PET procedures increased by 21% between 2005 and 2010, accounting for 900,000 procedures in 2011. The rapidly increasing demand for vascular imaging procedures drives the growth of the market.
Key players in the vascular imaging systems market
Some of the key players in the global market include Siemens AG, General Electric Company, Hitachi Ltd., and Koninklijke Philips N.V., Carestream Health, Inc., Hologic, Inc., Esaote S.P.A, Shimazdu Corporation, Canon Inc., Orthoscan, Inc., and Fujifilm Corporation.
GLOBAL VASCULAR IMAGING SYSTEMS MARKET SEGMENTATION
By End User